Condition
Trichuris Infection
Total Trials
5
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 2 (3)
Trial Status
Not Yet Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07258173Phase 2Not Yet RecruitingPrimary
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
NCT05914363Not ApplicableCompleted
Evaluating Impact of Improved Floors on Health
NCT03435718Phase 2Not Yet RecruitingPrimary
Efficacy of Oxfendazole in the Treatment of Trichuris Trichiura Infection in Adults
NCT04041453Phase 2CompletedPrimary
Albendazole Plus High Dose Ivermectin for Trichuriasis in Pediatric Patients
NCT04227834Not ApplicableUnknown
Soil-transmitted Helminth Reinfection Rates After Single and Repeated School Hygiene Education
Showing all 5 trials